Hymowitz N, Brezenoff H E
Pharmacol Biochem Behav. 1984 Jul;21(1):109-15. doi: 10.1016/0091-3057(84)90139-4.
N-(4-diethylamino-2-butynyl)-succinimide, or DKJ-21, is a muscarinic receptor antagonist with a high degree of selectivity for the central nervous system. In the present study of 6 rats maintained under a fixed-interval 50-sec schedule of food reinforcement, atropine and methylatropine reduced responding in a dose dependent manner, while DKJ-21 had little or no effect. Our findings suggest that the suppression caused by atropine and methylatropine may be the result of the dry mouth induced by these agents. Doses of DKJ-21 which had no effect on schedule performance antagonized the rate-lowering effects of physostigmine in all of the animals. Neither atropine nor methylatropine consistently antagonized the inhibitory effects of physostigmine. Some antagonism may be inferred, however, from the findings that response rates were suppressed less by combinations of atropine and physostigmine than by either drug alone.
N-(4-二乙氨基-2-丁炔基)琥珀酰亚胺,即DKJ-21,是一种对中枢神经系统具有高度选择性的毒蕈碱受体拮抗剂。在本研究中,对6只按照固定间隔50秒食物强化程序饲养的大鼠进行实验,阿托品和甲基阿托品以剂量依赖的方式减少反应,而DKJ-21几乎没有影响。我们的研究结果表明,阿托品和甲基阿托品引起的抑制作用可能是这些药物诱导口干的结果。对程序表现无影响的DKJ-21剂量可拮抗所有动物中毒扁豆碱的降低速率作用。阿托品和甲基阿托品均未持续拮抗毒扁豆碱的抑制作用。然而,从阿托品和毒扁豆碱联合使用比单独使用任何一种药物对反应率的抑制作用更小这一发现中,可以推断出一些拮抗作用。